Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study
Keywords: پیوند در برابر بیماری میزبان; allo-HSCT; allogeneic hematopoietic stem cell transplantation; IDA; idarubicin; AML; acute myeloid leukemia; ALL; acute lymphocytic leukemia; OS; overall survival; DFS; disease-free survival; RR; relapse rate; BU; busulfan; CY; cyclophosphamide; VP-16; et